Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ryan Holder

Showing results (11-20 of 19) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 19 results.
ACS Chemical Neuroscience|May 23, 2018
Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH<sub>2</sub> TemplateAleksandar Todorovic, Cody J Lensing, Jerry Ryan Holder, et al.
Journal of Medicinal Chemistry|April 29, 2005
N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytesAleksandar Todorovic, Jerry Ryan Holder, Rayna M Bauzo, et al.
Biochemistry|June 26, 2007
Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphismsZhimin Xiang, Irina D Pogozheva, Nicholas B Sorenson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2020
Half-life extension of peptidic APJ agonists by N-terminal lipid conjugationAnthony B Reed, Brian A Lanman, Jerry Ryan Holder, et al.
Journal of Medicinal Chemistry|December 5, 2008
Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptorLes P Miranda, Jerry Ryan Holder, Licheng Shi, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1Justin K Murray, Kaustav Biswas, J Ryan Holder, et al.
Nucleic Acid Therapeutics|July 23, 2021
Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver DiseaseJustin K Murray, Jason Long, Lei Liu, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of ObesityBin Wu, James R Falsey, Chawita Netirojjanakul, et al.
ACS Chemical Biology|August 12, 2017
Engineering Antibody Reactivity for Efficient Derivatization to Generate Na<sub>V</sub>1.7 Inhibitory GpTx-1 Peptide-Antibody ConjugatesKaustav Biswas, Thomas E Nixey, Justin K Murray, et al.
Pageof 2

Showing results (11-20 of 19) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 19 results.
ACS Chemical Neuroscience|May 23, 2018
Discovery of Melanocortin Ligands via a Double Simultaneous Substitution Strategy Based on the Ac-His-dPhe-Arg-Trp-NH<sub>2</sub> TemplateAleksandar Todorovic, Cody J Lensing, Jerry Ryan Holder, et al.
Journal of Medicinal Chemistry|April 29, 2005
N-terminal fatty acylated His-dPhe-Arg-Trp-NH(2) tetrapeptides: influence of fatty acid chain length on potency and selectivity at the mouse melanocortin receptors and human melanocytesAleksandar Todorovic, Jerry Ryan Holder, Rayna M Bauzo, et al.
Biochemistry|June 26, 2007
Peptide and small molecules rescue the functional activity and agonist potency of dysfunctional human melanocortin-4 receptor polymorphismsZhimin Xiang, Irina D Pogozheva, Nicholas B Sorenson, et al.
Bioorganic & Medicinal Chemistry Letters|August 29, 2020
Half-life extension of peptidic APJ agonists by N-terminal lipid conjugationAnthony B Reed, Brian A Lanman, Jerry Ryan Holder, et al.
Journal of Medicinal Chemistry|December 5, 2008
Identification of potent, selective, and metabolically stable peptide antagonists to the calcitonin gene-related peptide (CGRP) receptorLes P Miranda, Jerry Ryan Holder, Licheng Shi, et al.
Bioorganic & Medicinal Chemistry Letters|June 27, 2015
Sustained inhibition of the NaV1.7 sodium channel by engineered dimers of the domain II binding peptide GpTx-1Justin K Murray, Kaustav Biswas, J Ryan Holder, et al.
Nucleic Acid Therapeutics|July 23, 2021
Identification and Optimization of a Minor Allele-Specific siRNA to Prevent PNPLA3 I148M-Driven Nonalcoholic Fatty Liver DiseaseJustin K Murray, Jason Long, Lei Liu, et al.
Journal of Medicinal Chemistry|April 6, 2026
Discovery of AMG 133, a Glucose-Dependent Insulinotropic Polypeptide Receptor Antagonist and Glucagon-Like Peptide 1 Receptor Agonist Antibody-Drug Conjugate for the Treatment of ObesityBin Wu, James R Falsey, Chawita Netirojjanakul, et al.
ACS Chemical Biology|August 12, 2017
Engineering Antibody Reactivity for Efficient Derivatization to Generate Na<sub>V</sub>1.7 Inhibitory GpTx-1 Peptide-Antibody ConjugatesKaustav Biswas, Thomas E Nixey, Justin K Murray, et al.
Pageof 2